Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Halo Diagnostics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Halo Diagnostics

Halo Diagnostics

Series B

HALO Diagnostics: A tech company revolutionizing radiology with life-changing patient insights.

HQ
Ann Arbor, MI, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize radiology, HALO Diagnostics focuses on creating life-changing patient insights and outcomes. The company offers precision diagnostics, early detection, and personalized medicine services, specializing in areas such as prostate and breast cancer screening, diagnosis, and treatment. Their market focus includes comprehensive courses for conditions like COPD and neuro health, aiming to provide advanced, patient-centric care.

Notable affiliated individuals include leading experts in radiology and personalized medicine. HALO Diagnostics has attracted significant investment from key players in the healthcare technology sector. The company has achieved rapid growth, marked by its innovative diagnostic solutions and impactful patient outcomes, establishing itself as a transformative force in the radiology field.

Halo Diagnostics - Quick Facts

When was Halo Diagnostics founded?

Halo Diagnostics was founded in 2019.

Where is Halo Diagnostics' headquarters located?

Halo Diagnostics' headquarters is located in Ann Arbor, MI, US.

When was Halo Diagnostics' last funding round?

Halo Diagnostics' most recent funding round was for $19M (USD) in March 2021.

How much has Halo Diagnostics raised to-date?

As of Mar 4, 2021, Halo Diagnostics has raised a total of $19M (USD).

How many employees does Halo Diagnostics have?

Halo Diagnostics has 375 employees as of Feb 5, 2024.

Halo Diagnostics - Classification

Ownership
  • Private
Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Diagnostics
  • Treatment
Tags
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 513200Software Publishers
  • 330000Manufacturing
  • 510000Information
  • 325000Chemical Manufacturing
  • 513000Publishing Industries
  • 325410Pharmaceutical and Medicine Manufacturing
  • 513210Software Publishers
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 7300Business Services
  • 5040Professional And Commercial Equipment And Supplies
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 7372Prepackaged Software